Terms: = Lung cancer AND WIF1, WIF-1, 11197, ENSG00000156076 AND Treatment
23 results:
1. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.
Simiene J; Dabkeviciene D; Stanciute D; Prokarenkaite R; Jablonskiene V; Askinis R; Normantaite K; Cicenas S; Suziedelis K
BMC Cancer; 2023 Sep; 23(1):857. PubMed ID: 37697308
[TBL] [Abstract] [Full Text] [Related]
2. The status of wif1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.
Shen Z; Chen C; Sun J; Huang J; Liu S
J Cancer Res Clin Oncol; 2021 Aug; 147(8):2239-2248. PubMed ID: 34037837
[TBL] [Abstract] [Full Text] [Related]
3. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract] [Full Text] [Related]
4. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (wif1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract] [Full Text] [Related]
5. Triptolide exhibits antitumor effects by reversing hypermethylation of WIF‑1 in lung cancer cells.
Mao X; Tong J; Wang Y; Zhu Z; Yin Y; Wang Y
Mol Med Rep; 2018 Sep; 18(3):3041-3049. PubMed ID: 30015908
[TBL] [Abstract] [Full Text] [Related]
6. Wnt inhibitory factor-1-mediated autophagy inhibits Wnt/β-catenin signaling by downregulating dishevelled-2 expression in non-small cell lung cancer cells.
Luo X; Ye S; Jiang Q; Gong Y; Yuan Y; Hu X; Su X; Zhu W
Int J Oncol; 2018 Aug; 53(2):904-914. PubMed ID: 29916529
[TBL] [Abstract] [Full Text] [Related]
7. RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.
Bachet JB; Bouché O; Taieb J; Dubreuil O; Garcia ML; Meurisse A; Normand C; Gornet JM; Artru P; Louafi S; Bonnetain F; Thirot-Bidault A; Baumgaertner I; Coriat R; Tougeron D; Lecomte T; Mary F; Aparicio T; Marthey L; Taly V; Blons H; Vernerey D; Laurent-Puig P
Ann Oncol; 2018 May; 29(5):1211-1219. PubMed ID: 29438522
[TBL] [Abstract] [Full Text] [Related]
8. miR-181c contributes to cisplatin resistance in non-small cell lung cancer cells by targeting Wnt inhibition factor 1.
Zhang H; Hu B; Wang Z; Zhang F; Wei H; Li L
Cancer Chemother Pharmacol; 2017 Nov; 80(5):973-984. PubMed ID: 28956120
[TBL] [Abstract] [Full Text] [Related]
9. The triptolide derivative MRx102 inhibits Wnt pathway activation and has potent anti-tumor effects in lung cancer.
Reno TA; Tong SW; Wu J; Fidler JM; Nelson R; Kim JY; Raz DJ
BMC Cancer; 2016 Jul; 16():439. PubMed ID: 27400883
[TBL] [Abstract] [Full Text] [Related]
10. Dietary compound isoliquiritigenin prevents mammary carcinogenesis by inhibiting breast cancer stem cells through wif1 demethylation.
Wang N; Wang Z; Wang Y; Xie X; Shen J; Peng C; You J; Peng F; Tang H; Guan X; Chen J
Oncotarget; 2015; 6(12):9854-76. PubMed ID: 25918249
[TBL] [Abstract] [Full Text] [Related]
11. Neuropilin-2 expression is inhibited by secreted Wnt antagonists and its down-regulation is associated with reduced tumor growth and metastasis in osteosarcoma.
Ji T; Guo Y; Kim K; McQueen P; Ghaffar S; Christ A; Lin C; Eskander R; Zi X; Hoang BH
Mol Cancer; 2015 Apr; 14():86. PubMed ID: 25890345
[TBL] [Abstract] [Full Text] [Related]
12. Norcantharidin inhibits Wnt signal pathway via promoter demethylation of wif-1 in human non-small cell lung cancer.
Xie J; Zhang Y; Hu X; Lv R; Xiao D; Jiang L; Bao Q
Med Oncol; 2015 May; 32(5):145. PubMed ID: 25814287
[TBL] [Abstract] [Full Text] [Related]
13. Specific reversal of tumor-suppressor gene promoter hypermethylation with bovine oocyte extract.
Wang Z; Gao H; Wang H; Ren X; Bao L; Sa R; Wang J; Bai H; Yu H
Oncol Rep; 2013 Jul; 30(1):179-84. PubMed ID: 23670097
[TBL] [Abstract] [Full Text] [Related]
14. DNA Methylation status of Wnt antagonist SFRP5 can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer.
Zhu J; Wang Y; Duan J; Bai H; Wang Z; Wei L; Zhao J; Zhuo M; Wang S; Yang L; An T; Wu M; Wang J
J Exp Clin Cancer Res; 2012 Sep; 31(1):80. PubMed ID: 23009178
[TBL] [Abstract] [Full Text] [Related]
15. Hypomethylation effects of curcumin, demethoxycurcumin and bisdemethoxycurcumin on wif-1 promoter in non-small cell lung cancer cell lines.
Liu YL; Yang HP; Gong L; Tang CL; Wang HJ
Mol Med Rep; 2011; 4(4):675-9. PubMed ID: 21484077
[TBL] [Abstract] [Full Text] [Related]
16. Aberrant promoter methylation of wif-1 and SFRP1, 2, 4 genes in mesothelioma.
Kohno H; Amatya VJ; Takeshima Y; Kushitani K; Hattori N; Kohno N; Inai K
Oncol Rep; 2010 Aug; 24(2):423-31. PubMed ID: 20596629
[TBL] [Abstract] [Full Text] [Related]
17. Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
Rubin EM; Guo Y; Tu K; Xie J; Zi X; Hoang BH
Mol Cancer Ther; 2010 Mar; 9(3):731-41. PubMed ID: 20197388
[TBL] [Abstract] [Full Text] [Related]
18. Procaine and procainamide inhibit the Wnt canonical pathway by promoter demethylation of wif-1 in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablons DM; You L
Oncol Rep; 2009 Dec; 22(6):1479-84. PubMed ID: 19885602
[TBL] [Abstract] [Full Text] [Related]
19. Promoter demethylation of wif-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract] [Full Text] [Related]
20. wif-1 promoter region hypermethylation as an adjuvant diagnostic marker for non-small cell lung cancer-related malignant pleural effusions.
Yang TM; Leu SW; Li JM; Hung MS; Lin CH; Lin YC; Huang TJ; Tsai YH; Yang CT
J Cancer Res Clin Oncol; 2009 Jul; 135(7):919-24. PubMed ID: 19085002
[TBL] [Abstract] [Full Text] [Related]
[Next]